ABSTRACT
Objective:
In this study, it was aimed to evaluate the effects of diabetes and anthropometric measurements on disease severity in patients with Obstructive Sleep Apnea syndrome (OSAS).
Materials and Methods:
Seventy-three volunteers, 20 female and 53 male, who were 30 years old and over, diagnosed with OSAS, who applied to Marmara University Institute of Neurological Sciences Sleep Unit and İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Neurology, Sleep Disorders Center, participated in the study. The demographic characteristics of the patients were determined by the STOP-BANG test, face-to-face questionnaire, and anthropometric measurements were made.
Results:
In the study, it was observed that the OSAS risk determined by STOP-BANG test in men and women was correlated with the measurements of weight, waist circumference, chest circumference and neck circumference, except body mass index and hip circumference. Diabetes was detected in 17 (23.2%) of OSAS patients, but no significant relationship was found between OSAS severity and anthropometric measurements.
Conclusion:
In our study, it was determined that there is a significant relationship between anthropometric measurements and OSAS severity, and this is especially evident in male gender. A higher rate of diabetes was found in OSAS patients compared to the general population. However, it was observed that anthropometric measurements did not play a role among the mechanisms underlying the relationship between OSAS and diabetes.
Keywords:
Obstructive Sleep Apnea syndrome, diabetes, anthropometric measurements
References
1Ursavaş A. Yeni Uyku Bozuklukları Sınıflaması (ICSD-3) uykuda solunum bozukluklarında neler değişti. Güncel Göğüs Hastalık Seri 2014;2:139-51.
2Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan C, Peter H. Effect of Nasal continous positive airway pressure treatment on blood pressure in patiens with obstructive sleep apnea. Circulation 2003;107:68-73.
3Yıldırım Y, Yılmaz S, Güven M, Kılınç F, Kara A, Yılmaz Z, Kırbaş G, Tuzcu A, Aydın F. Evalution of anthropometric and metabolic parameters in obstructive sleep apnea. Pulm Med 2015;2015:1-6.
4Pagel JF. Obstructive sleep apnea (OSA) in primary care: evidence-based practice. J Am Board Fam Med 2007;20:392-8.
5Vale J, Manueal P, Oliveira E, Oliveira A, Silva E, Melo V, Sousa M, Alexandre J, Gil I, Sanchez A, Nascimento E, Torres A. Obstructive sleep apnea and diabetes mellitus. Rev Port Pneumol 2015;21:55-60.
6Tuomilehto H, Seppa J, Uusitupa M, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Pukkila M, Vanninen E, Tuomilehto J, Gylling H, Kuopio Sleep Apnea Group. The impact of weight reduction in the prevention of the progression of obstructive sleep apnea: an explanatory analysis of a 5-year observational follow-up trial. Sleep Med 2014;15:329-35.
7Acar HV, Kaya A, Yücel F, Erdem M, Günal SE, Özgen F, Dikmen B. Obstrüktif Uyku Apnesi tarama testi olarak kullanılan STOP-Bang testinin türk popülasyonunda geçerliliğinin saptanması. Turk J Anaesth Reanim 2013;41:115-20.
8Chung F, Liao P, Farney R. Correlation between the STOP-Bang score and the severity of obstructive sleep apnea. Anesthesiology 2015;122:1436-7.
9Ben-noun L, Sohar E, Laor A. Neck circumference as a simple screening measure for identifying overweight and obese patients. Obes Res 2001;9:470-7.
10Gabbay IE, Lavie P. Age and gender-related characteristics of obstructive sleep apnea. Sleep Breath 2012;16:453-60.
11O’connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med 2000:161:1465-72.
12Şahin H, Özol D, Yıldırım Z, Bozkurt B, Yiğitoğlu MR. Obezite parametrelerinin obstrüktif uyku apnesi üzerine etkisi. Yeni Tıp Derg 2011;28:142-5.
13Bozkurt NC, Beysel S, Karbek B, Ozturk Unsal I, Cakir E, Delibasi T. Visceral obesity mediates the association between metabolic syndrome and obstructive sleep apnea syndrome. Metab Syndr and Relat Disord 2016;14:217-21.
14Lim YH, Choi J, Kim KR, Shin J, Hwang KG, Ryu S, Cho SH. Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist–hip ratio. Ann Otol Rhinol Laryngol 2014;123:517-23.
15Brown MA, Goodwin JL, Silva GE, Behari A, Newman AB, Punjabi NM, Resnick HE, Robbins JA, Quan SF. The impact of sleep-disordered breathing on Body Mass Index (BMI): The Sleep Heart Health Study (SHHS). Southwest J Pulm Crit Care 2011;3:159-68.
16Ayık S, Akhan G, Peker Ş. Obstruktif uyku apne sendromlu olgularda obezite sıklığı ve ek hastalıklar. Turk Thorac J 2011:12:105-10.
17Ernst G, Bosio M, Salvado A, Dibur E, Nigro C, Borsini E. Difference between apnea-hypopnea index (AHI) and oxygen desaturation index (ODI): proportional increase associated with degree of obesity. Sleep Breath 2016;20:1175-83.
18Celen YT, Hedner J, Carlson J, Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: A 16-Year Follow-Up. J Clin Sleep Med 2010;6:244-50.
19Pinto JA, Ribeiro DK, Cavallini AFS, Duarte C, Freitas GS. Comorbidities associated with obstructive sleep apnea: a retrospective study. Int Arch Otorhinolaryngol 2016;20:145-50.
20Kent BD, Grote L, Ryan S, Pépin JL, Bonsignore MR, Tkacova R, Saaresranta T, Verbraecken J, Lévy P, Hedner J, McNicholas WT. Diabetes mellitus prevalence and control in sleep-disordered breathing The European Sleep Apnea Cohort (ESADA) Study. Chest 2014;146:982-90.
21Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-51.
22Jacome-Sosa MM, Parks EJ. Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol 2014;25:213-20.
23Kearney MT, Chowienczyk PJ, Brett SE, Sutcliffe A, Ritter JM, Shah AM. Acute haemodynamic effects of lipolysis-induced increase of free fatty acids in healthy men. Clin Sci (Lond) 2002;102:495-500.
24Engin AB. What is lipotoxicity? Adv Exp Med Biol 2017;960:197-220.
25Aron-Wisnewsky J, Clement K, Pepin JL. Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism 2016;65:1124-35.
26Nobili V, Cutrera R, Liccardo D, Pavone M, Devito R, Giorgio V, Verrillo E, Baviera G, Musso G. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/ insulin resistance. Am J Respir Crit Care Med 2014;189:66-76.
27Mesarwi OA, Shin MK, Drager LF, Bevans-Fonti S, Jun JC, Putcha N, Torbenson MS, Pedrosa RP, Lorenzi-Filho GL, Steele KE, Schweitzer MA, Magnuson TH, Lidor AO, Schwartz AR, Polotsky VY. Lysyl oxidase as a serum biomarker of liver fibrosis in patients with severe obesity and obstructive sleep apnea. Sleep 2015;38:1583-91.
28Mirrakhimov AE, Polotsky VY. Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? Front Neurol 2012;3:149.
29Gu C, Younas H, Jun JC. Sleep apnea: An overlooked cause of lipotoxicity? Med Hypotheses 2017;108:161-5.
30Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities. Chest 2015;147:266-74.
31Quercioli A, Mach F, Montecucco F. Infammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 2010;14:261-9.a
